Casey Stevens

Casey Stevens is a scientist II, process development at Verve Therapeutics, with expertise in the production and biophysical characterization of biologics. Prior to joining Verve, Dr. Stevens worked as a strain and process development scientist at Cytovance Biologics, engineering microbial strains and fermentation conditions for manufacturing. He received his B.S. in biological science from Colorado State University and his Ph.D. in chemistry and biochemistry from the University of Oklahoma, where his work focused on the functional characterization and inhibition of novel drug targets for the treatment of drug-resistant tuberculosis.